COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
The Glutamate Synapse as a Therapeutic Target - 1st Edition - ISBN: 9780444827548, 9780080862415

The Glutamate Synapse as a Therapeutic Target, Volume 116

1st Edition

Series Volume Editors: O.P. Ottersen I.A. Langmoen L. Gjerstad
Hardcover ISBN: 9780444827548
eBook ISBN: 9780080862415
Imprint: Elsevier Science
Published Date: 9th November 1998
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

I. Glutamate Release and Transport. 1. Calcium channels coupled to glutamate release (T.J. Turner). 2. Presynaptic modulation of glutamate release ( D.G. Nicholls). 3. Properties and localization of glutamate transporters (N.C. Danbolt, F.A. Chaudhry, Y. Dehnes, K.P. Lehre, K. Ullensvang, J. Storm-Mathisen). 4. Physiological and pathological operation of glutamate transporters (B. Billups, D. Rossi, T. Oshima, O. Warr, M. Takahashi, M. Sarantis, M. Szatkowski, D. Attwell). 5. Control of the time course of glutamatergic synaptic currents (L. Trussell). II. Glutamate Synthesis and Translocation to Vesicles. 6. Synthesis of glutamate and its regulation (E. Kvamme). 7. Uptake of glutamate into synaptic vesicles (F. Fonnum, E.M. Fykse, S. Roseth). III. Glutamate Receptors. 8. Synaptic arrangement of glutamate receptors (Y. Takumi, L. Bergersen, A.S. Landsend, E. Rinvik, O.P. Ottersen). 9. Anchoring of glutamate receptors at the synapse (Y.-P. Hsueh, M. Sheng). 10. The organization and regulation of non-NMDA receptors in neurons (R.J. Wenthold, K.W. Roche). 11. AMPA receptors: molecular and functional diversity (K. Borges, R. Dingledine). 12. Molecular determinants of NMDA receptor pharmacological diversity (D.T. Monaghan, V.J. Andaloro, D.A. Skifter). 13. Modulation of NMDA receptors (J.F. MacDonald, X.-G. Xiong, W.-Y. Lu, R. Raouf, B.A. Orser). 14. Metabotropic glutamate receptors and neurodegeneration (V. Bruno, G. Battaglia, A. Copani, G. Casabona, M. Storto, V. De Giorgi Cerevini, R. Ngomba, F. Nicoletti). IV. Glutamate Toxicity and Cell Death in the Cental Nervous System. 15. Intracellular calcium and magnesium: critical determinants of excitotoxicity? (I.J. Reynolds). 16. Neurodegeneration and glutamate induced oxidative stress (N. Nakao, P. Brundin). 17. Glutamate induced cell death: apoptosis or necrosis? (M. Ankarcrona). 18. Synaptic plasticity in ischemia: Role of NMDA receptors (V. Crépel, P. Congar, L. Aniksztejn, H. Gozlan, C. Hammond, Y. Ben-Ari). 19. Glutamate in the human brain: possible roles in synaptic transmission and ischemia (J. Berg-Johnsen, T.S. Haugstad, I.A. Langmoen). 20. Glutamate and its receptors in the pathophysiology of brain and spinal cord injuries (B. Alessandri, R. Bullock). 21. Glutamate toxicity in chronic neurodegenerative disease (E. Lancelot, M. Flint Beal). V. Conditions of Perturbed Glutamatergic Transmission. 22. Electrophysiological substrates for focal epilepsies (J.G.R. Jefferys, R.D. Traub). 23. Involvement of glutamate in human epileptic activities (R.D. Scheyer). 24. Glutamate receptors in epilepsy (A. Chapman). 25. Effects of antiepileptic drugs on the activation of glutamate receptors (E. Taubøll, L. Gjerstad). 26. Antiepileptic drug treatment: clinical considerations and concerns (E. Brodtkorb). 27. The glutamate synapse: a target in the pharmacological management of hyperalgesic pain states (M.O. Urban, G.F. Gebhart). 28. The glutamate synapse in neuropsychiatric disorders: focus on schizophrenia and Alzheimer's disease (N.B. Farber, J.W. Newcomer, J.W. Olney). VI. Perspectives. 29. The glutamate synapse as a therapeutical target: perspectives for the future (B. Meldrum).


This volume provides a comprehensive update on basic glutamate research, from a clinical perspective. Thus, emphasis is placed on how the different molecular players at the glutamate synapse interact to produce a postsynaptic response, how synaptic transmission is perturbed in epilepsy and other pathological conditions, and how glutamate may acquire toxic properties and lead to acute or chronic neurodegeneration. Promising targets for therapeutic strategies are discussed.

A coherent picture is provided of the glutamate synapse and its molecular organization. The book therefore deals with each step in the signal process, from synthesis and vesicular uptake of glutamate to its clearance following receptor activation.


© Elsevier Science 1998
9th November 1998
Elsevier Science
Hardcover ISBN:
eBook ISBN:

Ratings and Reviews

About the Series Volume Editors

O.P. Ottersen

Affiliations and Expertise

Dept. of Anatomy, Institute of Basic Medical Sciences, University of Oslo, POB 1105 Blindern, N-0317 Oslo, Norway

I.A. Langmoen

Affiliations and Expertise

Dept. of Neurosurgery, The National Hospital, Rikshospitalet, N-0027 Oslo, Norway

L. Gjerstad

Affiliations and Expertise

Nevrologisk avdeling, Rikshospitalet, N-0027 Oslo, Norway